PreprintCited by 32CRISPR and Genetic EngineeringGenomics and Rare DiseasesGenetic Associations and Epidemiology

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Joint genotypic and phenotypic outcome modeling improves base editing variant effect quantification

Open access

Preprint — published as 10.1038/s41588-024-01726-6

Abstract

CRISPR base editing screens are powerful tools for studying disease-associated variants at scale. However, the efficiency and precision of base editing perturbations vary, confounding the assessment of variant-induced phenotypic effects. Here, we provide an integrated pipeline that improves the estimation of variant impact in base editing screens. We perform high-throughput ABE8e-SpRY base editing screens with an integrated reporter construct to measure the editing efficiency and outcomes of each gRNA alongside their phenotypic consequences. We introduce BEAN, a Bayesian network that accounts for per-guide editing outcomes and target site chromatin accessibility to estimate variant impacts. We show this pipeline attains superior performance compared to existing tools in variant classification and effect size quantification. We use BEAN to pinpoint common variants that alter LDL uptake, implicating novel genes. Additionally, through saturation base editing of LDLR , we enable accurate quantitative prediction of the effects of missense variants on LDL-C levels, which aligns with measurements in UK Biobank individuals, and identify structural mechanisms underlying variant pathogenicity. This work provides a widely applicable approach to improve the power of base editor screens for disease-associated variant characterization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2023.09.08.23295253

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 131

  1. 10.1038/s41576-019-0127-1 · DOI
  2. 10.1038/s41586-018-0579-z · DOI · Paper page
  3. 10.1038/nprot.2016.135 · DOI · Paper page
  4. 10.1016/j.tibtech.2011.04.003 · DOI
  5. 10.1126/science.3457470 · DOI
  6. 10.1016/j.ygeno.2015.06.005 · DOI · Paper page
  7. 2022, High-content CRISPR screening, Nature Reviews Methods Primers, 2, 1
  8. 10.1126/science.1247005 · DOI · Paper page
  9. 10.1126/science.1246981 · DOI · Paper page
  10. 10.1038/nature17946 · DOI · Paper page
  11. 10.1038/nature24644 · DOI · Paper page
  12. 10.1038/s41576-018-0059-1 · DOI · Paper page
  13. 10.1016/j.cell.2021.01.012 · DOI · Paper page
  14. 2023, Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens, Science, 380, eadh7699, 10.1126/science.adh7699 · DOI · Paper page
  15. 2023, Massively parallel base editing to map variant effects in human hematopoiesis, Cell, 186, 2456, 10.1016/j.cell.2023.03.035 · DOI
  16. 10.1016/j.cell.2021.01.041 · DOI
  17. 2023, Scanning mutagenesis of the voltage-gated sodium channel NaV1.2 using base editing, Cell Rep, 42, 112563, 10.1016/j.celrep.2023.112563 · DOI
  18. 2023, Base editing screens map mutations affecting interferon-γ signaling in cancer, Cancer Cell, 41, 288, 10.1016/j.ccell.2022.12.009 · DOI
  19. 2021, Single-nucleotide-level mapping of DNA regulatory elements that control fetal hemoglobin expression, Nat. Genet, 53, 869, 10.1038/s41588-021-00861-8 · DOI
  20. 10.1038/s41587-022-01276-4 · DOI
  21. 10.1038/s41388-019-0968-2 · DOI
  22. 2021, Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction, Genome Biol, 22, 80, 10.1186/s13059-021-02305-2 · DOI
  23. 10.1038/s41467-022-28884-7 · DOI
  24. 2023, Base editor scanning charts the DNMT3A activity landscape, Nat. Chem. Biol, 19, 176, 10.1038/s41589-022-01167-4 · DOI
  25. 10.1038/s41467-020-15796-7 · DOI
  26. 10.1101/2023.04.12.536656 · DOI
  27. 2023, Base editor screens for in situ mutational scanning at scale, Mol. Cell, 83, 2167, 10.1016/j.molcel.2023.06.009 · DOI
  28. 10.1016/j.cell.2020.05.037 · DOI · Paper page
  29. 2022, EPIC: Inferring relevant cell types for complex traits by integrating genome-wide association studies and single-cell RNA sequencing, PLoS Genet, 18, e1010251, 10.1371/journal.pgen.1010251 · DOI
  30. 10.1038/s41588-018-0081-4 · DOI · Paper page
  31. 2015, Familial hypercholesterolemia, Cardiol. Clin, 33, 169, 10.1016/j.ccl.2015.01.001 · DOI
  32. 10.1038/scientificamerican0784-72 · DOI
  33. 10.1136/heartjnl-2017-312706 · DOI
  34. 10.1093/nar/gkt1113 · DOI · Paper page
  35. 2023, Systematic elucidation of genetic mechanisms underlying cholesterol uptake, Cell Genomics, 3, 100304, 10.1016/j.xgen.2023.100304 · DOI · Paper page
  36. 10.1055/s-2008-1040407 · DOI · Paper page
  37. 10.1038/s41587-020-0453-z · DOI · Paper page
  38. 10.1126/science.aba8853 · DOI · Paper page
  39. 2021, Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing, Nucleic Acids Res, 49, 2390, 10.1093/nar/gkab052 · DOI
  40. 2023, HMGN1 enhances CRISPR-directed dual-function A-to-G and C-to-G base editing, Nat. Commun, 14, 2430, 10.1038/s41467-023-38193-2 · DOI
  41. 2020, A simple new approach to variable selection in regression, with application to genetic fine mapping, J. R. Stat. Soc. Series B Stat. Methodol, 82, 1273, 10.1111/rssb.12388 · DOI · Paper page
  42. 2020, Functionally informed fine-mapping and polygenic localization of complex trait heritability, Nat. Genet, 52, 1355, 10.1038/s41588-020-00735-5 · DOI · Paper page
  43. 10.1371/journal.pgen.1009285 · DOI · Paper page
  44. 2023, Base editing rescue of spinal muscular atrophy in cells and in mice, Science, 380, eadg6518, 10.1126/science.adg6518 · DOI
  45. 10.1016/J.MOLCEL.2021.03.032 · DOI
  46. 2019, Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides, CRISPR J, 2, 51, 10.1089/crispr.2018.0036 · DOI
  47. Liu, G. , Yin, K. , Zhang, Q. , Gao, C. & Qiu, J.-L . Modulating chromatin accessibility by transactivation and targeting proximal dsgRNAs enhances Cas9 editing efficiency in vivo. Genome Biol. 20, 145 (2019). · DOI
  48. 10.2337/db20-2194-PUB · DOI
  49. 10.1186/s13059-014-0554-4 · DOI · Paper page
  50. Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015). · DOI
  51. 10.1101/gr.245571.118 · DOI
  52. Daley, T. P. et al. CRISPhieRmix: a hierarchical mixture model for CRISPR pooled screens. Genome Biol. 19, 159 (2018). · DOI
  53. 10.1038/nature10808 · DOI
  54. 10.1016/J.AJHG.2021.05.001 · DOI
  55. 2021, Motif-Raptor: a cell type-specific and transcription factor centric approach for post-GWAS prioritization of causal regulators, Bioinformatics, 37, 2103, 10.1093/bioinformatics/btab072 · DOI
  56. 10.1016/j.cell.2014.08.009 · DOI
  57. 2020, Occupancy maps of 208 chromatin-associated proteins in one human cell type, Nature, 583, 720, 10.1038/s41586-020-2023-4 · DOI · Paper page
  58. 10.1038/nature13835 · DOI · Paper page
  59. 2004, Identification of the DNA binding element of the human ZNF333 protein, J. Biochem. Mol. Biol, 37, 663
  60. 10.1073/pnas.91.10.4514 · DOI
  61. 10.1038/41798 · DOI
  62. 1989, Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins, J. Biol. Chem, 264, 21682, 10.1016/S0021-9258(20)88240-4 · DOI · Paper page
  63. 10.1146/annurev.biochem.74.082803.133354 · DOI · Paper page
  64. 10.1093/nar/27.1.260 · DOI
  65. 10.1038/ng.2797 · DOI
  66. 10.1101/2023.01.06.23284280 · DOI
  67. Chen, T. & Guestrin, C . XGBoost: A Scalable Tree Boosting System. arXiv [cs.LG] (2016). · DOI · Paper page
  68. 2022, Coronary artery disease risk of familial hypercholesterolemia genetic variants independent of clinically observed longitudinal cholesterol exposure, Circ. Genom. Precis. Med, 15, e003501
  69. 2020, Proteostasis Regulation in the Endoplasmic Reticulum: An Emerging Theme in the Molecular Pathology and Therapeutic Management of Familial Hypercholesterolemia, Front. Genet, 11, 570355, 10.3389/fgene.2020.570355 · DOI
  70. 10.1110/ps.8.7.1492 · DOI
  71. 2016, Functional analysis of the p.(Leu15Pro) and p.(Gly20Arg) sequence changes in the signal sequence of LDL receptor, Atherosclerosis, 250, 9, 10.1016/j.atherosclerosis.2016.04.022 · DOI
  72. 10.1016/0022-2836(85)90046-4 · DOI
  73. 10.1074/jbc.M110.105718 · DOI
  74. 10.1093/NAR/GKAB1061 · DOI · Paper page
  75. Webb, B. & Sali, A . Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 86, 2.9.1-2.9.37 (2016). · DOI · Paper page
  76. 10.1016/j.jmb.2016.12.004 · DOI
  77. 2023, DDMut: predicting effects of mutations on protein stability using deep learning, Nucleic Acids Res, 51, W122, 10.1093/nar/gkad472 · DOI
  78. 10.1126/science.4023714 · DOI
  79. 10.1186/gb-2010-11-10-r106 · DOI · Paper page
  80. Love, M. I. , Huber, W. & Anders, S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014). · DOI · Paper page
  81. 10.1038/s41586-020-2308-7 · DOI · Paper page
  82. 2017, Estimating the selective effects of heterozygous protein-truncating variants from human exome data, Nat. Genet, 49, 806, 10.1038/ng.3831 · DOI
  83. 10.1038/nmeth.3027 · DOI · Paper page
  84. 10.1038/gim.2015.30 · DOI · Paper page
  85. Brnich, S. E. et al. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 12, 3 (2019). · DOI
  86. 10.1016/j.jacc.2020.07.059 · DOI · Paper page
  87. 2019, Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years, J. Am. Heart Assoc, 8, e011433, 10.1161/JAHA.118.011433 · DOI
  88. 2016, A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries, Curr. Opin. Lipidol, 27, 388, 10.1097/MOL.0000000000000300 · DOI
  89. 2023, The landscape of tolerated genetic variation in humans and primates, Science, 380, eabn8153, 10.1126/science.abn8197 · DOI
  90. 10.1016/j.ajhg.2016.08.016 · DOI · Paper page
  91. 2012, Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis, Yale J. Biol. Med, 85, 19
  92. 10.1097/MOL.0000000000000114 · DOI · Paper page
  93. 2023, Systematic elucidation of genetic mechanisms underlying cholesterol uptake, Cell Genomics, 3, 100304, 10.1016/j.xgen.2023.100304 · DOI · Paper page
  94. 10.1371/journal.pgen.1009285 · DOI · Paper page
  95. 10.1038/s41587-019-0032-3 · DOI
  96. 10.1016/j.cell.2020.05.037 · DOI · Paper page
  97. Anders, S. & Huber, W . Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010). · DOI · Paper page
  98. Love, M. I. , Huber, W. & Anders, S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014). · DOI · Paper page
  99. 10.1186/s12859-016-1015-8 · DOI
  100. Hutton, E. R. , Vakoc, C. R. & Siepel, A . ACE: a probabilistic model for characterizing gene-level essentiality in CRISPR screens. Genome Biol. 22, 278 (2021). · DOI
  101. Imkeller, K. , Ambrosi, G. , Boutros, M. & Huber, W. gscreend: modelling asymmetric count ratios in CRISPR screens to decrease experiment size and improve phenotype detection. Genome Biol. 21, 53 (12/2020). · DOI
  102. Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014). · DOI · Paper page
  103. Li, W. et al. Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR. Genome Biol. 16, 281 (2015). · DOI
  104. 10.1101/gr.245571.118 · DOI
  105. Daley, T. P. et al. CRISPhieRmix: a hierarchical mixture model for CRISPR pooled screens. Genome Biol. 19, 159 (2018). · DOI
  106. Huang, C. , Li, G. , Wu, J. , Liang, J. & Wang, X . Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction. Genome Biol. 22, 80 (2021). · DOI
  107. 10.1093/nar/gks596 · DOI
  108. 10.1038/nmeth.1923 · DOI · Paper page
  109. 10.25080/majora-92bf1922-011 · DOI
  110. 2021, Motif-Raptor: a cell type-specific and transcription factor centric approach for post-GWAS prioritization of causal regulators, Bioinformatics, 37, 2103, 10.1093/bioinformatics/btab072 · DOI
  111. 10.1016/j.cell.2014.08.009 · DOI
  112. 10.1093/NAR/GKAA913 · DOI · Paper page
  113. Wheeler, T. J. , Clements, J. & Finn, R. D . Skylign: a tool for creating informative, interactive logos representing sequence alignments and profile hidden Markov models. BMC Bioinformatics 15, 7 (2014). · DOI
  114. 10.1093/nar/gkt376 · DOI
  115. Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011). · DOI
  116. 10.1093/nar/gkq313 · DOI · Paper page
  117. 10.1371/journal.pmed.1001779 · DOI · Paper page
  118. 10.1038/s41586-022-04558-8 · DOI · Paper page
  119. Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, (2021). · DOI
  120. 10.1038/s41587-019-0054-x · DOI · Paper page
  121. McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, (2016). · DOI · Paper page
  122. 10.1101/gr.3715005 · DOI · Paper page
  123. 10.1101/2023.01.06.23284280 · DOI
  124. Chen, T. & Guestrin, C . XGBoost: A Scalable Tree Boosting System. arXiv [cs.LG] (2016). · DOI · Paper page
  125. 10.1016/j.cpc.2010.04.018 · DOI
  126. Schrödinger, LLC . The PyMOL Molecular Graphics System, Version 1.8. Preprint at (2015).
  127. 10.1126/science.4023714 · DOI
  128. 10.1093/bioinformatics/btp163 · DOI · Paper page
  129. 10.1093/NAR/GKAB1061 · DOI · Paper page
  130. Webb, B. & Sali, A . Comparative protein structure modeling using MODELLER. Curr. Protoc. Protein Sci. 86, 2.9.1–2.9.37 (2016). · DOI · Paper page
  131. 2023, DDMut: predicting effects of mutations on protein stability using deep learning, Nucleic Acids Res, 51, W122, 10.1093/nar/gkad472 · DOI

Metadata

Authors
Ryu, J., Barkal, S., Yu, T., Jankowiak, M., Zhou, Y., Francoeur, M., Phan, Q. V., Li, Z., Tognon, M., Brown, L., Love, M. I., Lettre, G., Ascher, D. B., Cassa, C. A., Sherwood, R. I., & Pinello, L.
Affiliations
  • Broad Institute (US)
  • Brigham and Women's Hospital (US)
  • Baker Heart and Diabetes Institute (AU)
  • University of North Carolina at Chapel Hill (US)
  • Montreal Heart Institute (CA)
Corresponding author
  • Cassa, Christopher A.
  • Sherwood, Richard I.
  • Pinello, Luca
Venue
Nature Genetics
Publisher
openRxiv
Published
2023-09-10
Volume
56
Issue
5
Pages
925-937
ISSN
1061-4036 (ISSN-L)
OpenAlex
W4395074959
Cited by
32
References
3
Citations by year
2026: 15 · 2025: 13 · 2024: 3 · 2023: 1
FWCI
4.21
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Nature Genetics (publishedVersion)
  • medRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion, other-oa)
  • PubMed Central (submittedVersion, cc-by-nc-nd)
Funders
  • U.S. Department of Health and Human Services (1R35HG010717-01, 1R01HL164409, UM1HG012010, R01-HG010372, 1R01GM143249)
  • American Cancer Society
  • American Heart Association
  • National Organization for Rare Disorders
  • State Government of Victoria
  • Medical Research Council
  • National Health and Medical Research Council (1174405)
  • National Heart, Lung, and Blood Institute (R01HL164409)
  • National Human Genome Research Institute (R56HG012681, R35HG010717, R01HG010372, UM1HG012010)
  • National Institute of General Medical Sciences (R01GM143249)
  • National Institute of Environmental Health Sciences (P30ES010126)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
variant effect prediction, Bayesian networks, beans, chromatin accessibility, LDL uptake, LDL receptor, disease-associated variants, regulatory variants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review